Healthcare -
Biotechnology - NASDAQ - US
$ 493.756
-0.384 %
$ 52.4 B
Market Cap
12.27
P/E
REGN - CASH & EQUIVALENTS
Cash & Equivalents REGN - Regeneron Pharmaceuticals, Inc.
2.49 B
LAST VALUE
-10.49%
2 YEAR CAGR
8.99%
5 YEAR CAGR
14.39%
10 YEAR CAGR